- Poster presentation
- Open Access
PReS-FINAL-2317: Clinical presentation, management and outcome of Kawasaki disease (4 years reviews)
© Benamer et al.; licensee BioMed Central Ltd. 2013
Published: 5 December 2013
Kawasaki disease(KD) is an autoimmune disease and one of the most common vasculitis of childhood, it has many clinical manifestation but most serious effect is on the heart where it can cause severe coronary artery aneurysms in untreated children
to shade light on our experience on clinical Presentation, management and outcome of KD.
Sitting: all medical department of Benghazi children hospital.)) Subject: all the patients who diagnosed as KD during study period(from Jan 2009-dec 201 2).
Design of study
Retrospective descriptive case series study.
data collected by reviwing their admission files.
There are 28 patient diagnosed as KD during study period.
Male to female ratio 2.1:1
34% of the cases are atypical KD.
. 79% below 5 years of age...
Peak admissions in October, November, December
The frequency of clinical criteria for diagnosis of KD:
Fever in all the patients (mean duration of fever before admission 8 days), oropharyngeal changes 22 (78%), extremity changes 21 (75%) cervical lymphadenitis 20 (71%), skin rash 18(64%). conjunctivitis 16 (57%).
Other associated symptoms and signs: vomiting 13(46%), diarrhea 11(40%), cough 8(29%), arthritis 2 (7%), hepatomegaly were present in 4(14%), splenomegaly 2 (7%), jaundice 2(7%) no case with meningitis.
Echocardiogram done in 26 patients, 17 (69%) normal, 9 (31%) abnormal coronary arteries.
Regarding treatment: 18 patients receive sandglobulin; aspirin received by 18 patients during admission. no patient receive steroids.
7 patients diagnosed in late stage and 3 patients left LAMA.
Antibiotics used for 17 patients.
we have significant delay in diagnosis and high rate of coronary aneurysm.
Disclosure of interest
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.